Patents by Inventor Hans Loibner

Hans Loibner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of antibodies for the vaccination against cancer
    Publication number: 20040265318
    Abstract: Described is use of antibodies which are directed against human cellular membrane antigens for the vaccination against cancer diseases.
    Type: Application
    Filed: July 28, 2004
    Publication date: December 30, 2004
    Applicant: Igeneon Krebs-Immunotherapie Forschungs-und Entwicklungs-AG
    Inventors: Helmut Eckert, Hans Loibner
  • Method for producing a vaccine
    Publication number: 20040191242
    Abstract: There is disclosed a method of producing an autologous-antibody-containing vaccine, which method is characterized by the following steps:
    Type: Application
    Filed: March 8, 2004
    Publication date: September 30, 2004
    Inventors: Gottried Himmler, Hans Loibner, Helmut Eckert, Otto Doblhoff-Dier, Ralf Kircheis, Manfred Schuster, Erich Wasserbauer, Gunter Waxenecker
  • Use of polyclonal immunoglobulins
    Publication number: 20040151717
    Abstract: The invention relates to the use of a polyclonal immunoglobulin preparation for producing a vaccine formulation, containing antibodies of various specific natures for immunising individuals of the same species from which the immunoglobulins are supplied. Said actively immunising preparation can be used, for example, for the prophylaxis or treatment of cancer, auto-immune diseases, allergies and susceptibility to viral, bacterial or fungal infections.
    Type: Application
    Filed: January 29, 2004
    Publication date: August 5, 2004
    Inventors: Hans Loibner, Gottfried Himmler
  • Method for producing vaccines containing a heat-treated mixture consisting of at least one antigen and of at least one adjuvant
    Publication number: 20030143221
    Abstract: A method of preparing a vaccine formulation comprising at least one antigen and at least one adjuvant is described, which method is characterized in that at least one antigen is mixed with at least one adjuvant and the mixture subsequently is heat-treated at a temperature of at least 80° C. for a period of time of at least 5 minutes.
    Type: Application
    Filed: September 12, 2002
    Publication date: July 31, 2003
    Inventors: Hans Loibner, Helmut Eckert
  • Polysaccharide-polypeptide conjugate
    Publication number: 20030120033
    Abstract: Disclosed is a method of producing a polysaccharide-polypeptide conjugate by reacting a polysaccharide with a polypeptide which contains at least one free amino group, wherein a polysaccharide carrier comprising vicinal hydroxyl groups is oxidized under ring opening to create vicinal aldehyde groups and is reacted with one or more base-instable antigenic polypeptide(s) containing at least one free amino group, the polypeptide(s) being bound directly to the polysaccharide carrier via at least one azomethine bond.
    Type: Application
    Filed: September 17, 2002
    Publication date: June 26, 2003
    Inventors: Hans Loibner, Helmut Eckert
  • Monoclonal antibodies and their use
    Publication number: 20020146410
    Abstract: Monoclonal murine internal image anti-idiotypic antibodies (Ab2) to monoclonal antibodies BR55-2 (Ab1), process for the production thereof and use for prophylactic and/or therapeutic immunization against HIV-infections, against cancer of epithelial origin and against small cell lung cancer.
    Type: Application
    Filed: March 5, 2002
    Publication date: October 10, 2002
    Inventors: Helmut Eckert, Herbert Jaksche, Evelyne Janzek, Hans Loibner, Dieter Scholz
  • Humanized antibodies that recognize difucosyl Lewis blood group antigens Y-6 and B-7-2
    Patent number: 5562903
    Abstract: Humanized monoclonal antibodies that recognize the difucosyl Lewis blood group antigens Y-6 and B-7-2 are disclosed. The antibodies have a humanized light chain variable region and a humanized heavy chain variable region with CDRs from antibody BR55-2. Fragments of the antibodies and pharmaceutical compositions containing them are also disclosed.
    Type: Grant
    Filed: April 22, 1993
    Date of Patent: October 8, 1996
    Assignee: Sandoz Ltd.
    Inventors: Man S. Co, Hans Loibner
  • Monoclonal antibody in destruction of small cell lung carcinoma
    Patent number: 5523085
    Abstract: Monoclonal antibody BR55-2 and fragments thereof having the specificity of monoclonal antibody BR55-2, and variants thereof, are useful in the treatment of small cell lung carcinoma.
    Type: Grant
    Filed: January 24, 1995
    Date of Patent: June 4, 1996
    Assignee: Sandoz Ltd.
    Inventors: Hans Loibner, Dieter Scholz
  • 1-Nitro-aminoglycoside derivatives, pharmaceutical compositions containing them and such derivatives for use as pharmaceuticals
    Patent number: 4503046
    Abstract: Hydroxymethylated aminoglycoside derivatives which are useful, in particular as anti-bacterially active antibiotics.
    Type: Grant
    Filed: August 3, 1982
    Date of Patent: March 5, 1985
    Assignee: Sandoz Ltd.
    Inventors: Hans Loibner, Wolfgang Streicher, Peter St/u/ tz